Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · Real-Time Price · USD
5.24
-0.16 (-2.96%)
At close: Oct 8, 2025, 4:00 PM EDT
5.40
+0.16 (3.05%)
After-hours: Oct 8, 2025, 7:11 PM EDT
Ekso Bionics Holdings Market Cap
Ekso Bionics Holdings has a market cap or net worth of $13.63 million as of October 8, 2025. Its market cap has decreased by -38.86% in one year.
Market Cap
13.63M
Enterprise Value
14.11M
1-Year Change
-38.86%
Ranking
Category
Stock Price
$5.24
Market Cap Chart
Since March 31, 2014, Ekso Bionics Holdings's market cap has decreased from $250.40M to $13.63M, a decrease of -94.56%. That is a compound annual growth rate of -22.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 14.10M | 5.22% |
| Dec 31, 2024 | 13.40M | -62.36% |
| Dec 29, 2023 | 35.60M | 128.21% |
| Dec 30, 2022 | 15.60M | -53.57% |
| Dec 31, 2021 | 33.60M | -34.12% |
| Dec 31, 2020 | 51.00M | 74.06% |
| Dec 31, 2019 | 29.30M | -62.29% |
| Dec 31, 2018 | 77.70M | -39.11% |
| Dec 29, 2017 | 127.60M | 46.50% |
| Dec 30, 2016 | 87.10M | -16.57% |
| Dec 31, 2015 | 104.40M | -2.34% |
| Dec 31, 2014 | 106.90M | -57.31% |
| Mar 31, 2014 | 250.40M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |